国内首家A+H 医药上市公司，引入云南白药进行混改。上海医药前身始于中国医药公司上海分公司，通过合并上海医药工业公司等企业，逐步形成覆盖制药、分销和中药材的全产业链布局。1994 年，原上海第四制药厂改制后在上交所上市，2010 年通过吸收合并上实医药和中西药业，更名为“上海医药集团股份有限公司”，实现A 股复牌上市。2011 年在香港联交所上市，成为中国首家“A+H”股医药企业。2022 年 4...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.